Curtis: New FDA-Approved Pacemakers Allow for More Personalized Treatment

Updated May 30, 2017 This content is archived.

An article about FDA approval of three cardiac resynchronization therapy pacemakers for the treatment of patients with heart failure quotes Anne B. Curtis, MD, SUNY Distinguished Professor, Charles and Mary Bauer Professor and chair of medicine. “These new pacemakers allow clinicians to provide more personalized therapy treatment options,” she said.